Prolyl hydroxylase domain-containing protein inhibitors as stabilizers of hypoxia-inducible factor: small molecule-based therapeutics for anemia

By Yan Lin   Colandrea Vincent J   Hale Jeffrey J  

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 9, 2010-09 ,pp. : 1219-1245

Informa Healthcare

Access to resources Recommend Favorite

Minocycline accelerates hypoxia-inducible factor-1 alpha degradation and inhibits hypoxia-induced neovasculogenesis through prolyl hydroxylase, von Hippel–Lindau-dependent pathway

By Li Ching-Hao   Liao Po-Lin   Yang Ya-Ting   Huang Shih-Hsuan   Lin Cheng-Hui   Cheng Yu-Wen   Kang Jaw-Jou  

Archives of Toxicology, Vol. 88, Iss. 3, 2014-03 ,pp. : 659-671

Springer Publishing Company

Access to resources Recommend Favorite

Hypoxia-inducible Factor-1alpha: Molecular-targeted Therapy for Hepatocellular Carcinoma

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 9, 2013-07 ,pp. : 1295-1304

Bentham Science Publishers

Access to resources Recommend Favorite

Protein kinases and the Hypoxia-Inducible Factor-1, two switches in angiogenesis

By  

Current Pharmaceutical Design, Vol. 9, Iss. 7, 2003-03 ,pp. : 531-541

Bentham Science Publishers

Access to resources Recommend Favorite

Hypoxia-Inducible Vascular Endothelial Growth Factor Gene Therapy Using the Oxygen-Dependent Degradation Domain in Myocardial Ischemia

By Kim Hyun   Lim Soyeon   Moon Hyung-Ho   Kim Sung   Hwang Ki-Chul   Lee Minhyung   Kim Sun   Choi Donghoon  

Pharmaceutical Research, Vol. 27, Iss. 10, 2010-10 ,pp. : 2075-2084

Springer Publishing Company

Access to resources Recommend Favorite